The competition between Walmart and Amazon appears to be heating up. Walmart beat revenue expectations, but fell short of estimates for profit in the holiday quarter and reported a slowdown in online sales. Greg Alvo, CEO of OrderGroove and Chris Versace, Chief Investment Officer at Tematica Research join The Long and The Short to discuss the future of America's largest retailer.
Alvo reminds us that Walmart is growing its omnichannel approach. Just because e-commerce sales slowed down doesn't mean its overall business is slowing down. Versace says online demand exceeded expectations this year and Walmart is trying to navigate this new trend. He also says the pullback in e-commerce investments could be a long-term play for Walmart as it fights to compete with Amazon.
Plus, how will Walmart expand its offerings to be equal to Amazon? Versace says continuing to focus on selling fresh foods and finding partners that will continue to help expand products on Jet.com are key. He also suggests that Walmart thinks about expanding its private label brands and bumping up quality to compete with Amazon.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
